Interactions Between Nitric Oxide and Angiotensin II on Renal Cortical and Papillary Blood Flow
- 1 November 1997
- journal article
- Published by Wolters Kluwer Health in Hypertension
- Vol. 30 (5) , 1175-1182
- https://doi.org/10.1161/01.hyp.30.5.1175
Abstract
Abstract This study examined the role of angiotensin II (Ang II) on the effects of nitric oxide (NO) synthesis blockade on renal cortical and papillary blood flow in innervated and denervated kidneys of volume-expanded Munich-Wistar rats with hormonal influences on the kidney that were held constant by intravenous infusion. Cortical (CBF) and papillary (PBF) blood flow were measured by laser-Doppler flowmetry. A low dose of N ω -nitro- l -arginine methyl ester ( L -NAME, 3.7 nmol · kg −1 · min −1 ) reduced CBF only in innervated kidneys, and this effect was abolished by subsequent administration of valsartan (an AT 1 antagonist). L-NAME 3.7 nmol · kg −1 · min −1 improved PBF autoregulation by lowering PBF to the range of 100 to 140 mm Hg of perfusion pressure, and this effect was attenuated or abolished by valsartan in innervated and denervated kidneys, respectively. These results indicate that the cortical and medullary vasoconstriction induced by a low dose of L-NAME are caused by potentiation of the vasoconstrictor influence of renal sympathetic nerves and Ang II. A higher dose of L-NAME (37 nmol · kg −1 · min −1 ) lowered CBF and PBF in both innervated and denervated kidneys. This effect of L-NAME on the cortical circulation was abolished by valsartan, but this AT 1 antagonist had no effect on the medullary vasoconstriction produced by NO synthesis blockade. Therefore, a higher dose of L-NAME induces a renal cortical vasoconstriction through potentiation of the renin-angiotensin system, whereas the fall of PBF seen after L-NAME 37 nmol · kg −1 · min −1 seems to be caused primarily by NO suppression. This Ang II potentiation produced by L-NAME in the renal cortex seems to be mediated by AT 1 receptors, because it was unaffected by PD123319 (an AT 2 antagonist). The results of the present study indicate that NO is an important modulator of the vasoconstrictor influence of Ang II in the renal cortical circulation of the rat. However, although there are some interactions between NO and renal nerves and Ang II on the medullary circulation, the renal medullary vasoconstriction produced by L-NAME appears to be caused primarily by NO suppression, with little influence of the renal vasoconstrictor systems.Keywords
This publication has 28 references indexed in Scilit:
- Renal responses to intra-arterial administration of nitric oxide donor in dogs.Hypertension, 1993
- Salt-induced increase in arterial pressure during nitric oxide synthesis inhibition.Hypertension, 1993
- Cardiovascular responses to long-term blockade of nitric oxide synthesis.Hypertension, 1993
- Sodium and angiotensin in hypertension induced by long-term nitric oxide blockade.Hypertension, 1993
- Angiotensin blockade reverses hypertension during long-term nitric oxide synthase inhibition.Hypertension, 1993
- Sustained hypertension induced by orally administered nitro-L-arginine.Hypertension, 1993
- Neural mechanism of hypertension by nitric oxide synthase inhibitor in dogs.Hypertension, 1993
- Angiotensin dependence of endothelium-mediated renal hemodynamics.Hypertension, 1992
- Role of nitric oxide in renal papillary blood flow and sodium excretion.Hypertension, 1992
- Pressure-diuresis in volume-expanded rats. Cortical and medullary hemodynamics.Hypertension, 1988